A 2012 paper by PM Ridker et. al published in The Lancet titled “Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.” lives up to its title and outlines the cardiovascular benefits of using statin drugs (including Lipitor, Zocor, Crestor, and others) along with the risk for for diabetes associated with the use of these drugs: “In view of evidence that statin therapy increases risk of diabetes, the balance of benefit and risk of these drugs in primary prevention has become controversial.”

In this paper, the Ridker team evaluated results from the JUPITER trial, a large study that had found an increased risk for diabetes among statin users.  The Ridker team found that “for those with diabetes risk factors, a total of 134 vascular events or deaths were avoided for every 54 new cases of diabetes diagnosed.”

This study concluded that the cardiovascular benefit of using statin drugs outweighed the risk for diabetes.  That very well may be the case, and in fact is a positive thing.  The problem is that the manufacturers of Lipitor and other statin drugs failed time and again to notify users that there was an increased risk for diabetes associated at all.  While the benefits may outweigh the risks, it is essential that users make fully informed healthcare decisions.

As a result of this failure to warn, a number of Lipitor lawsuits have been filed.  If you or a loved one used Lipitor and suffered diabetes as a result, you too may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Lipitor lawyers at the information provided below.  We have the compassion, experience, and resources required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529


Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.